SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-026335
Filing Date
2024-07-05
Accepted
2024-07-05 16:01:25
Documents
13
Period of Report
2024-06-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62523
  Complete submission text file 0001493152-24-026335.txt   235315

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20240628.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ocx-20240628_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocx-20240628_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3537
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 241102612
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)